Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
Clinical trial NCT02439320 · COMPLETED
Trial details
- NCT number
- NCT02439320
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-07-01
- Enrollment
- 2231
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.